To include your compound in the COVID-19 Resource Center, submit it here.

Fluidigm, Life Technologies deal

Fluidigm received rights to Life Technologies' IP covering PCR related technologies, while Life Technologies received

Read the full 151 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE